These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20678199)

  • 1. Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum.
    LaPan P; Brady J; Grierson C; Fleming M; Miller D; Sypek J; Fu B
    BMC Pulm Med; 2010 Aug; 10():40. PubMed ID: 20678199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.
    Chaudhuri R; McSharry C; Brady J; Donnelly I; Grierson C; McGuinness S; Jolly L; Weir CJ; Messow CM; Spears M; Miele G; Nocka K; Crowther D; Thompson J; Brannigan M; Lafferty J; Sproule M; Macnee W; Connell M; Murchison JT; Shepherd MC; Feuerstein G; Miller DK; Thomson NC
    J Allergy Clin Immunol; 2012 Mar; 129(3):655-663.e8. PubMed ID: 22305682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
    Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
    Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation.
    Skjøt-Arkil H; Clausen RE; Nguyen QH; Wang Y; Zheng Q; Martinez FJ; Hogaboam CM; Han M; Klickstein LB; Larsen MR; Nawrocki A; Leeming DJ; Karsdal MA
    BMC Pulm Med; 2012 Jul; 12():34. PubMed ID: 22818364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.
    Vernooy JH; Lindeman JH; Jacobs JA; Hanemaaijer R; Wouters EF
    Chest; 2004 Dec; 126(6):1802-10. PubMed ID: 15596677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.
    Haq I; Lowrey GE; Kalsheker N; Johnson SR
    Thorax; 2011 Nov; 66(11):970-6. PubMed ID: 21730350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease.
    He J; Turino GM; Lin YY
    Exp Lung Res; 2010 Nov; 36(9):548-57. PubMed ID: 20815658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
    Beeh KM; Beier J; Kornmann O; Buhl R
    Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-12 activates protease-activated receptor-1, upregulates placenta growth factor, and leads to pulmonary emphysema.
    Hou HH; Wang HC; Cheng SL; Chen YF; Lu KZ; Yu CJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L432-L442. PubMed ID: 29722565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
    Ziora D; Dworniczak S; Kozielski J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease.
    Cataldo D; Munaut C; Noël A; Frankenne F; Bartsch P; Foidart JM; Louis R
    Int Arch Allergy Immunol; 2000 Nov; 123(3):259-67. PubMed ID: 11112863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases.
    Lagente V; Le Quement C; Boichot E
    Expert Opin Ther Targets; 2009 Mar; 13(3):287-95. PubMed ID: 19236151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
    Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
    Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
    Hao W; Li M; Zhang Y; Zhang C; Wang P
    Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.
    Guiot J; Henket M; Corhay JL; Moermans C; Louis R
    PLoS One; 2017; 12(2):e0171344. PubMed ID: 28178340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
    Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.